5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes by nephrectomy status in METEOR, a randomized phase 3 trial of cabozantinib (cabo) vs everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Tannir, N. M.; Powles, T.; Escudier, B. J.; Donskov, F.; Grünwald, V.; Sternberg, C. N.; Schmidinger, M.; Schoffski, P.; Szczylik, C.; Peltola, K. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Pazopanib exposure response assessment as adjuvant therapy for patients with localized or locally advanced renal cell carcinoma (RCC) following nephrectomy
    Meeting Abstract

    Sternberg, C. N.; Donskov, F.; Haas, N. B.; Doehn, C.; Russo, P.; Elmeliegy, M.; Banerjee, H.; Aimone, P.; Voi, M.; Motzer, R. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Nomogram to assess survival benefit of new over historical agents as salvage therapy for metastatic urothelial carcinoma (mUC) in non-randomized trials
    Meeting Abstract

    Sonpavde, G.; Pond, G. R.; Rosenberg, J. E.; Choueiri, T. K.; Bellmunt, J.; Regazzi, A. M.; Mullane, S. A.; Necchi, A.; Raggi, D.; Lee, J. L.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Halabi, S.; Carbone, E.; Fernandez, C.; Chen, Y.; Autio, K. A.; Rathkopf, D. E.; Kampel, L.; Morris, M. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Baseline CTC subtype to predict outcomes on mCRPC patients (pts) receiving enzalutamide (E) compared to abiraterone (A)
    Meeting Abstract

    Scher, H. I.; Jendrisak, A.; Schreiber, N. A.; McLaughlin, B.; Graf, R. P.; Rodriguez, A.; Fleisher, M.; Lee, J.; Kelvin, J.; Wang, Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical versus radiographic progression and overall survival for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) from COU-AA-302
    Meeting Abstract

    Ryan, C. J.; Kheoh, T.; Scher, H. I.; De Porre, P.; Yu, M. K.; Morris, M. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Sunitinib in patients with metastatic renal cell carcinoma: Clinical outcome according to IMDC risk group
    Meeting Abstract

    Rini, B. I.; Hutson, T. E.; Figlin, R. A.; Lechuga, M.; Valota, O.; Serfass, L.; Casey, M.; Motzer, R. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Powles, T.; Fizazi, K.; Gillessen, S.; Drake, C. G.; Rathkopf, D. E.; Narayanan, S.; Green, M. C.; Mecke, A.; Schiff, C.; Sweeney, C.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Performance of a high-intensity 508-gene circulating-tumor DNA (ctDNA) assay in patients with metastatic breast, lung, and prostate cancer
    Meeting Abstract

    Razavi, P.; Li, B.; Abida, W.; Aravanis, A.; Jung, B.; Shen, R.; Hou, C.; De Bruijn, I.; Gnerre, S.; Lim, R. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or without androgen deprivation therapy for unfavorable-risk prostate cancer
    Meeting Abstract

    Patel, S. A.; Chen, M. H.; Loffredo, M.; Renshaw, A. A.; Kantoff, P. W.; D'Amico, A. V.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save